- Home
- PTGX vs DKL Comparison
PTGX vs DKL Comparison
Compare PTGX & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- DKL
- Stock Information
- Founded
- PTGX 2006
- DKL 2012
- Country
- PTGX United States
- DKL United States
- Employees
- PTGX N/A
- DKL N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- PTGX Health Care
- DKL Energy
- Exchange
- PTGX Nasdaq
- DKL Nasdaq
- Market Cap
- PTGX 2.3B
- DKL 2.3B
- IPO Year
- PTGX 2016
- DKL N/A
- Fundamental
- Price
- PTGX $38.75
- DKL $39.93
- Analyst Decision
- PTGX Strong Buy
- DKL Buy
- Analyst Count
- PTGX 8
- DKL 4
- Target Price
- PTGX $57.13
- DKL $44.25
- AVG Volume (30 Days)
- PTGX 528.6K
- DKL 197.1K
- Earning Date
- PTGX 02-21-2025
- DKL 02-25-2025
- Dividend Yield
- PTGX N/A
- DKL 10.91%
- EPS Growth
- PTGX N/A
- DKL N/A
- EPS
- PTGX 4.23
- DKL 2.83
- Revenue
- PTGX $434,433,000.00
- DKL $984,922,000.00
- Revenue This Year
- PTGX $445.33
- DKL N/A
- Revenue Next Year
- PTGX N/A
- DKL $4.99
- P/E Ratio
- PTGX $9.16
- DKL $14.13
- Revenue Growth
- PTGX 624.05
- DKL N/A
- 52 Week Low
- PTGX $24.22
- DKL $37.02
- 52 Week High
- PTGX $48.89
- DKL $46.50
- Technical
- Relative Strength Index (RSI)
- PTGX 52.47
- DKL 33.02
- Support Level
- PTGX $37.50
- DKL $40.75
- Resistance Level
- PTGX $39.37
- DKL $42.00
- Average True Range (ATR)
- PTGX 1.32
- DKL 0.93
- MACD
- PTGX 0.16
- DKL -0.35
- Stochastic Oscillator
- PTGX 67.70
- DKL 7.66
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes Pipelines and Transportation; Pipelines and Transportation and Investments in Pipeline Joint Ventures. It generates maximum revenue from the Pipelines and Transportation segment. The pipelines and Transportation segment consist of pipelines, tanks, offloading facilities, trucks, and ancillary assets, which provide crude oil gathering and crude oil, intermediate and refined products transportation and storage services in support of Delek Holdings' refining operations in Tyler, Texas, El Dorado, Arkansas and Spring, Texas.